Get the Stockscreener App
1.17
2.63%
0.03
Boundless Bio Inc stock is traded at $1.17, with a volume of 116.10K.
It is up +2.63% in the last 24 hours and down -1.68% over the past month.
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
See More
Previous Close:
$1.14
Open:
$1.1694
24h Volume:
116.10K
Relative Volume:
0.66
Market Cap:
$26.19M
Revenue:
-
Net Income/Loss:
$-61.06M
P/E Ratio:
-0.0817
EPS:
-14.3261
Net Cash Flow:
$-59.30M
1W Performance:
+0.86%
1M Performance:
-1.68%
6M Performance:
-40.31%
1Y Performance:
-67.95%
1-Day Range:
$1.155
$1.19
1-Week Range:
$1.09
$1.19
52-Week Range:
$1.00
$4.72
Boundless Bio Inc Stock (BOLD) Company Profile
Name
Boundless Bio Inc
Sector
Industry
Phone
(858) 766-9912
Address
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
1.17 | 26.19M | 0 | -61.06M | -59.30M | -14.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-13-24 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-22-24 | Initiated | Guggenheim | Buy |
| Apr-22-24 | Initiated | Leerink Partners | Outperform |
| Apr-22-24 | Initiated | Piper Sandler | Overweight |
View All
Boundless Bio Inc Stock (BOLD) Latest News
Can Boundless Bio Inc. hit a new high this monthJuly 2025 Outlook & Weekly Return Optimization Alerts - Newser
Boundless Bio Inc. Stock Poised for Technical Comeback2025 AllTime Highs & Short-Term High Return Ideas - beatles.ru
Smart tools for monitoring Boundless Bio Inc.’s price actionBreakout Watch & High Accuracy Swing Trade Signals - Newser
Building trade automation scripts for Boundless Bio Inc.2025 Trade Ideas & Weekly Momentum Picks - Newser
Using Ichimoku Cloud for Boundless Bio Inc. technicalsFed Meeting & High Conviction Trade Alerts - Newser
Backtesting results for Boundless Bio Inc. trading strategies2025 Price Momentum & Weekly Setup with ROI Potential - Newser
Boundless Bio Inc. stock outlook for YEARJuly 2025 Weekly Recap & Weekly High Potential Alerts - Newser
Best data tools to analyze Boundless Bio Inc. stockQuarterly Growth Report & Detailed Earnings Play Alerts - Newser
How to track smart money flows in Boundless Bio Inc.Quarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - Newser
Signal strength of Boundless Bio Inc. stock in tech scanners2025 Market Outlook & Long Hold Capital Preservation Tips - Newser
Momentum Traders Eye Boundless Bio Inc. for Quick Bounce2025 Market Overview & Weekly Hot Stock Watchlists - classian.co.kr
Is Boundless Bio Inc. forming a reversal patternJuly 2025 Highlights & Capital Protection Trade Alerts - Newser
Is Boundless Bio Inc. reversing from oversold territory2025 Valuation Update & High Conviction Buy Zone Alerts - Newser
Combining price and volume data for Boundless Bio Inc.Dollar Strength & Real-Time Volume Surge Alerts - Newser
What’s next for Boundless Bio Inc. stock priceRecession Risk & Safe Entry Point Identification - Newser
Is a relief rally coming for Boundless Bio Inc. holders2025 Top Decliners & Safe Capital Growth Tips - Newser
Is It Too Late to Sell Boundless Bio Inc.2025 Pullback Review & Community Verified Trade Alerts - realecononews.com
Momentum divergence signals in Boundless Bio Inc. chartAnalyst Downgrade & Long Hold Capital Preservation Tips - Newser
Statistical indicators supporting Boundless Bio Inc.’s strength2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Developing predictive dashboards with Boundless Bio Inc. dataWeekly Investment Report & Real-Time Volume Analysis - Newser
Boundless Bio Inc. stock volume spike explainedTrade Signal Summary & Long-Term Safe Investment Plans - Newser
Why Boundless Bio Inc. stock attracts strong analyst attentionJuly 2025 Drop Watch & Precise Swing Trade Alerts - classian.co.kr
Forecasting Boundless Bio Inc. price range with options data2025 Top Gainers & Smart Allocation Stock Tips - Newser
Historical volatility pattern of Boundless Bio Inc. visualizedRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Boundless Bio Inc Stock (BOLD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):